Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis

This PMCF study is to obtain patient feedback using online questionnaires. There will be no involvement from healthcare professionals (HCPs) or investigator sites. Up to 100 Patients are being recruited by My Health Focus through their website. The study is performed throughout the UK except Northern Ireland with no sites involved in this study. Patients apply directly to participate in the study and the testing and questionnaire responses are completed at home.

Participants needed: 100
Trial details
Biological sex: AllType: InterventionalSponsor: Dermal Laboratories LtdUpdated: Sep 14, 2026
Eligibility criteria

Patients with psoriasis of any severity previously diagnosed by a Healthcare Pro... [+2]

Does not regularly use an emollient [+5]

Status: Recruiting

A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema

A 4 week, open label, multi-centre (GP setting), post market clinical follow-up study with Doublebase Once in patients of any age and any severity of atopic eczema. The study will involve patients who are already using emollients as part of their treatment regime, switching to Doublebase Once. Patients will ideally apply the product once daily for 4 weeks and SCORAD assessments will be performed, and patient questionnaires will be completed. A subgroup of adult patients (up to 15 patients) will also undergo skin hydration measurements for the first 8 days to evaluate objective measurements of skin hydration in patients with atopic eczema. Photographs of the same, representative area of eczema will also be taken for all patients at baseline and after 4 weeks of using Doublebase Once.

Participants needed: 65
Trial details
Biological sex: AllType: InterventionalSponsor: Dermal Laboratories LtdUpdated: Mar 18, 2025Locations: 1
Eligibility criteria

ii) Patients with atopic eczema (personal history or combined personal and famil...